2024
Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation
Piccini J, Ahlsson A, Dorian P, Gillinov A, Kowey P, Mack M, Milano C, Noiseux N, Perrault L, Ryan W, Steinberg J, Voisine P, Waldron N, Gleason K, Titanji W, Leaback R, O’Sullivan A, Ferguson W, Benussi S, Investigators N, Akhter S, Andreas M, Benussi S, Castella M, Dalrymple-Hay M, El-Eshmawi A, Groh M, Hanke T, Jeanmart H, Katz M, McCullough J, Melby S, Miller J, Noiseux N, Romano M, Perrault L, Piccini J, Podgoreanu M, Ryan W, Sharma V, Shults C, Teman N, Voisine P, Whitson B, Wickbom A, Vallabhajosyula P, Yau T. Efficacy and Safety of Botulinum Toxin Type A for the Prevention of Postoperative Atrial Fibrillation. JACC Clinical Electrophysiology 2024, 10: 930-940. PMID: 38661602, DOI: 10.1016/j.jacep.2024.01.020.Peer-Reviewed Original ResearchPrevention of postoperative atrial fibrillationPostoperative atrial fibrillationCoronary artery bypass graftingRate of postoperative atrial fibrillationSafety of botulinum toxin type ACardiac surgeryPrimary endpointBotulinum toxin type AToxin type AAtrial fibrillationAssociated with increased morbidityRate of adverse eventsDose-ranging studyPlacebo-controlled trialOpen-chest cardiac surgeryType of surgeryEpicardial fat padsInjection of botulinum toxinArtery bypass graftingRandomized clinical trialsPlacebo-ControlledValve surgeryDouble-blindPlacebo groupContinuous AF
2015
Minimally Invasive Port Access Approach for Reoperations on the Mitral Valve
Vallabhajosyula P, Wallen T, Pulsipher A, Pitkin E, Solometo LP, Musthaq S, Fox J, Acker M, Hargrove WC. Minimally Invasive Port Access Approach for Reoperations on the Mitral Valve. The Annals Of Thoracic Surgery 2015, 100: 68-73. PMID: 25975939, DOI: 10.1016/j.athoracsur.2015.02.039.Peer-Reviewed Original ResearchConceptsPort-access groupPort-access approachInvasive port access approachMitral valveAccess groupConcomitant proceduresSternotomy approachNew York Heart Association class 2Aortic cross-clamping timeCardiopulmonary bypass timeCross-clamping timeMean hospital lengthAccess approachPostoperative strokeSternotomy groupBypass timeHospital lengthPostoperative echocardiographyPostoperative mortalityMV replacementSurgical indicationsMore patientsRetrospective reviewAtrial fibrillationMitral regurgitation